(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Private Equity Industry Banner
Mouse Scroll Icon
July 2023

Veralox Therapeutics Inc. Announces Jonathan Mow as Chief Executive Officer

Veralox Therapeutics has announced the appointment of Jonathan Mow as the company’s new Chief Executive Officer. Jonathan Mow brings over 25 years of experience in biotechnology management. He most recently served as the CEO of PhaseBio Pharmaceuticals.

Veralox Therapeutics is a biotechnology company focused on the development of innovative therapies.